Literature DB >> 15707771

Neuroprotective effects of the aqueous extract of the Chinese medicine Danggui-Shaoyao-san on aged mice.

Junping Kou1, Danni Zhu, Yongqing Yan.   

Abstract

Danggui-Shaoyao-san (DSS), a famous Chinese complex prescription, has been widely used for gynecological and obstetrical purposes for a long time, and recently it has gained much attention due to its therapeutic efficacy for senile dementia. In the present study, the effects of aqueous extract of Danggui-Shaoyao-san on naturally aged mice were examined to investigate the pharmacological basis for its therapeutic efficacy on senile dementia. The results showed that DSS significantly prolonged latency in a step-through test and increased brain index so as to improve impaired cognitive function of aged mice after oral administration at doses of 250 and 500 mg/kg for 3 months. Using high-performance liquid chromatography technique with electrochemical detection (HPLC-ECD), it was found that DSS increased the content of monoamine neurotransmitters such as norepinephrine (NE), dopamine (DA) and 5-hydroxytryptamine (5-HT) in brains of aged mice. Using transmission electron microscope, it was found that DSS dose-dependently protected the ultrastructure of brain cortex in aged mice. These results indicate that DSS ameliorates memory dysfunction, modulates metabolism of monoamine neurotransmitters and protects the ultrastructure of cortex changed by aging. These findings suggest that DSS may be a useful therapeutic agent for senile dementia, especially Alzheimer's disease (AD).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15707771     DOI: 10.1016/j.jep.2004.11.020

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  17 in total

Review 1.  Herbal medicine in the treatment of Alzheimer's disease.

Authors:  Jian-guo Wu; Yan-yan Wang; Zi-lv Zhang; Bin Yu
Journal:  Chin J Integr Med       Date:  2014-04-22       Impact factor: 1.978

Review 2.  Danggui-Shaoyao-San: New Hope for Alzheimer's Disease.

Authors:  Xin Fu; QiuHong Wang; ZhiBin Wang; HaiXue Kuang; Pinghui Jiang
Journal:  Aging Dis       Date:  2015-12-20       Impact factor: 6.745

Review 3.  Roles of Gut Microbiota in Pathogenesis of Alzheimer's Disease and Therapeutic Effects of Chinese Medicine.

Authors:  Ying-Xin Sun; Xi-Juan Jiang; Bin Lu; Qing Gao; Ye-Fei Chen; Dan-Bin Wu; Wen-Yun Zeng; Lin Yang; Hu-Hu Li; Bin Yu
Journal:  Chin J Integr Med       Date:  2020-09-01       Impact factor: 2.626

4.  Analgesic Effects of Danggui-Shaoyao-San on Various "Phenotypes" of Nociception and Inflammation in a Formalin Pain Model.

Authors:  Jun-Bin Yin; Ke-Cheng Zhou; Huang-Hui Wu; Wei Hu; Tan Ding; Ting Zhang; Li-Ying Wang; Jun-Ping Kou; Alan David Kaye; Wen Wang
Journal:  Mol Neurobiol       Date:  2015-12-12       Impact factor: 5.590

5.  Traditional used Plants against Cognitive Decline and Alzheimer Disease.

Authors:  Gunter Peter Eckert
Journal:  Front Pharmacol       Date:  2010-12-08       Impact factor: 5.810

6.  History and experience: a survey of traditional chinese medicine treatment for Alzheimer's disease.

Authors:  Ping Liu; Mingwang Kong; Shihe Yuan; Junfeng Liu; Ping Wang
Journal:  Evid Based Complement Alternat Med       Date:  2014-01-29       Impact factor: 2.629

7.  Effects of Danggui-Shaoyao-San on the Influence of Spatial Learning and Memory Induced by Experimental Tooth Movement.

Authors:  Hong-Shi Li; Jie Ke; Gui-Zhi Zhao; Li-An Wu; Jun-Ping Kou; Hong-Chen Liu
Journal:  Chin Med J (Engl)       Date:  2015-07-20       Impact factor: 2.628

8.  Mechanistic study on the antidepressant-like effect of danggui-shaoyao-san, a chinese herbal formula.

Authors:  Zhen Huang; Qing-Qiu Mao; Xiao-Ming Zhong; Zhao-Yi Li; Feng-Mei Qiu; Siu-Po Ip
Journal:  Evid Based Complement Alternat Med       Date:  2012-08-09       Impact factor: 2.629

9.  Dangguijakyak-San Protects against 1-Methyl-4-phenyl-1,2,3,6,-tetrahydropyridine-Induced Neuronal Damage via Anti-Inflammatory Action.

Authors:  Deok-Sang Hwang; Hyo Geun Kim; Jun-Bock Jang; Myung Sook Oh
Journal:  Evid Based Complement Alternat Med       Date:  2013-08-31       Impact factor: 2.629

10.  A Two-Year Treatment of Amnestic Mild Cognitive Impairment using a Compound Chinese Medicine: A Placebo Controlled Randomized Trial.

Authors:  Junying Zhang; Zhen Liu; Huamin Zhang; Caishui Yang; He Li; Xin Li; Kewei Chen; Zhanjun Zhang
Journal:  Sci Rep       Date:  2016-07-04       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.